International Cancer Imaging Society

Our Journal - Cancer Imaging

Our Journal 1
Our Journal 1


Cancer Imaging is the official journal of ICIS, an open access, peer-reviewed journal published by BioMed Central. Original articles, as well as reviews and editorials written by international imaging experts with a subspecialty focus on oncology, are published regularly online;  sign up for alerts to keep up-to-date with the latest articles. Cancer Imaging Impact factor for 2016 is 1.470.

The journal encompasses CT, MRI, ultrasound, single photon and positron emission tomography, including multimodality imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.

All articles published in Cancer Imaging are included in PubMed, the most widely used biomedical bibliographic database service, as well as Embase, EmCare, Google Scholar, MEDLINE, Science Citation Index and Scopus. The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature.

ICIS Members receive 15% discount on article-processing fees.

Submit your next manuscript to Cancer Imaging and take full advantage of the following:

Members Area

Subscribe to our mailing list

* indicates required
Email Format

Cancer / Oncology News From Medical News Today

Early indicator of esophageal cancer risk found in Barrett's cells

Published: Tue, 23 Aug 2016 14:00:00 GMT

Testing genetic diversity of Barrett's cells in food pipe could give early indication of which people with Barrett's have higher risk of esophageal cancer.

Gene therapy via ultrasound could offer new tool in fight against heart disease and cancer

Published: Tue, 23 Aug 2016 14:00:00 GMT

Combining ultrasound energy and microbubbles to poke holes in cells may prove to be a new tool in the fight against cardiovascular disease and cancer, according to researchers from the University...

Expecting the worst increases side-effects in breast cancer patients receiving adjuvant hormone therapy

Published: Tue, 23 Aug 2016 14:00:00 GMT

A study of women receiving hormone therapies such as tamoxifen as part of their treatment for breast cancer has found that the number and seriousness of side-effects they experienced were...

Breast density and risk may be useful for guiding mammography screening frequency

Published: Tue, 23 Aug 2016 12:00:00 GMT

Women between the ages of 50 and 74 may benefit from more or less frequent mammography screening than is generally recommended, depending on breast density and risk.

Socioeconomic factors - not race or ethnicity - influence survival of younger patients with multiple myeloma

Published: Tue, 23 Aug 2016 12:00:00 GMT

Advances in the treatment of multiple myeloma, a cancer that forms in a type of white blood cell, have led to improved survival predominantly among young and white patients, with less of an...

Asthma: Researchers at University of Liege have discovered a type of eosinophil that plays a protective and beneficial role

Published: Tue, 23 Aug 2016 07:00:00 GMT

With the right treatment schedule, medications known as hypoxia-activated prodrugs (HAPs) could help prevent drug resistance in a subtype of lung cancer, according to a study published in PLOS...

Increased eye cancer risk linked to pigmentation genes that dictate eye color

Published: Mon, 22 Aug 2016 15:00:00 GMT

New research identifies genetic mechanisms behind rare form of melanoma are also associated with genetic risk for skin melanoma.

'Born to be bad' or 'born to be benign' - testing cells for esophageal cancer risk

Published: Mon, 22 Aug 2016 14:00:00 GMT

Genetically analysing lesions in the food pipe could provide an early and accurate test for oesophageal cancer, according to research led by Queen Mary University of London (QMUL), Academic Medical...

Every decade of being overweight ups cancer risk for women

Published: Mon, 22 Aug 2016 13:00:00 GMT

AICR's evidence shows that carrying extra body fat increases risk for 11 types of cancer, including postmenopausal breast and endometrial.

How long does 'chemo brain' last?

Published: Fri, 19 Aug 2016 16:00:00 GMT

Chemo brain refers to a drop in cognitive ability following chemotherapy. A new study sets out to investigate how long this side effect might last.


Nuada Medical


20 June 2016

How I Read Cancer Imaging Studies: The Master Class Series

How I Read Cancer Imaging Studies: The Master Class Series

New articles in our masterclass series:

» Read more » Other news items